Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe
Authorisation EU/1/07/410/15-16 · Sandoz GmbH
- Licence holder
- Sandoz GmbH (all products →)
- Active substance
- Recombinant human erythropoietin alfa
- Dosage form
- Solution for injection in pre-filled syringe
- Routes of administration
- Intravenous use, Subcutaneous use
- ATC codes
- B03XA, B03XA01
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Similar biological application (Article 10(4) of Directive No 2001/83/EC)
Recombinant human erythropoietin alfa: supply and approvals
24 authorised products on the HPRA list contain Recombinant human erythropoietin alfa. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 410. The HPRA list does not say whether it is on sale.
Other medicines with Recombinant human erythropoietin alfa in Ireland
23 other products on the HPRA list contain Recombinant human erythropoietin alfa, from 3 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 3 000 IU/0.3 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 4 000 IU/0.4 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 5 000 IU/0.5 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 6 000 IU/0.6 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Abseamed 8 000 IU/0.8 mL solution for injection in a pre-filled syringe | Medice Arzneimittel Putter GmbH & Co. K.G | Centralised EU authorisation | Not stated |
| Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringe | Sandoz GmbH | Centralised EU authorisation | Not stated |
| Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringe | Sandoz GmbH | Centralised EU authorisation | Not stated |
| Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringe | Sandoz GmbH | Centralised EU authorisation | Not stated |
| Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringe | Sandoz GmbH | Centralised EU authorisation | Not stated |
All 24 products with Recombinant human erythropoietin alfa →
Other substances in ATC group B03XA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group B03XA with this product:
Xm01 drug substance epoetin theta (16) · Epoetin alfa (9) · Epoetin zeta (6) · Roxadustat (5) · Darbepoetin alfa (4) · Vadadustat (3)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Sandoz GmbH holds 67 products on the HPRA list, with 17 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.